Search For Lab Tests Here

 The Hepatitis C Antibody & Liver Function Panel is a comprehensive diagnostic tool used to detect the presence of hepatitis C virus (HCV) antibodies and assess liver function. This panel includes the Hepatitis C Antibody with Reflex to Quantitative HCV RNA PCR test, along with a series of liver function tests: Albumin, Albumin/Globulin Ratio, Alkaline Phosphatase, Alanine Transaminase (ALT), Aspartate Aminotransferase (AST), Bilirubin Direct, Bilirubin Indirect, Bilirubin Total, Globulin, and Protein Total. This panel is crucial for diagnosing HCV infection and evaluating the liver's health and functionality.

The Hepatitis C Antibody with HCV RNA Quantitative PCR test is a comprehensive diagnostic test used to detect and confirm the presence of the Hepatitis C virus (HCV) in the blood. It combines the initial screening for HCV antibodies with a quantitative polymerase chain reaction (PCR) test to measure the viral load.

The Hepatitis C Antibody Test with Reflex to RNA Quantitative PCR is a two-step test. The initial qualitative antibody screen detects past exposure to HCV and reports results as Reactive or Non-Reactive. If reactive, reflex PCR measures viral RNA to confirm active infection and determine viral load. Doctors use this test to diagnose hepatitis C, evaluate liver health, and guide treatment decisions, providing key information for accurate diagnosis and disease management.

The Hepatitis C Viral RNA Genotype Lipa Test analyzes RNA to determine the genotype of the hepatitis C virus. Genotyping is essential because HCV strains vary in treatment response and prognosis. This test provides key insights into viral behavior, supports treatment planning, and aids in monitoring patients with chronic hepatitis C, helping guide decisions that impact long-term liver health outcomes.

The Hepatitis C Viral RNA Quantitative Test measures the amount of hepatitis C virus (HCV) RNA in blood to determine viral load. This test confirms active infection, evaluates disease severity, and monitors response to antiviral therapy. High viral load indicates significant viral replication, while lower or undetectable levels suggest effective treatment or controlled infection. Doctors use this test to guide therapy, track progress, and manage long-term liver health.

Why pay $69 for Everlywell's Hepatitis C finger prick test kit when you can experience the convenience and affordablity of a Hepatitis C lab test with Ulta Lab Tests - compare now and save!

The Hepatitis A & B Titer Test Panel is a comprehensive diagnostic tool designed to evaluate an individual's immunity status or infection presence for Hepatitis A and Hepatitis B viruses. This panel combines serological assays that measure specific antibodies and antigens associated with Hepatitis A and B, providing crucial insights for clinical diagnosis, vaccination verification, and the assessment of immune response post-vaccination or post-exposure.

 The Hepatitis B Titer Test Panel is a diagnostic panel that comprises three essential tests designed to assess immunity, infection status, and antibody levels for the Hepatitis B virus (HBV). The panel includes the following tests: Hepatitis B Core Antibody Total, Hepatitis B Surface Antibody Quantitative, and Hepatitis B Surface Antigen with Reflex Confirmation.

The Acute Hepatitis Panel with Reflex to Confirmation detects recent or acute infection by hepatitis A (IgM), B (surface antigen, core IgM), and C (antibody with reflex to RNA PCR) using immunoassay. Reflex confirmation ensures accurate diagnosis for hepatitis B surface antigen positives and reactive HCV antibodies. Use is indicated for symptomatic patients with jaundice, dark urine, fatigue, abdominal pain, or elevated liver enzymes.

The Hepatitis B Core Antibody Total Test is a qualitative blood test that detects antibodies to the hepatitis B core antigen (anti-HBc) and reports results as Reactive or Non-Reactive. A reactive result may indicate past or ongoing infection, while a non-reactive result suggests no exposure. This test does not distinguish between IgM and IgG antibodies. Doctors use it to evaluate hepatitis B exposure, confirm infection history, and assess overall immune response.

The Hepatitis B Core Antibody Total Test with Reflex to IgM detects antibodies (anti-HBc) to the hepatitis B core antigen. If the total antibody test is reactive, reflex testing determines if IgM antibodies are present, which indicates recent or acute infection. A reactive total with non-reactive IgM suggests past or chronic infection. Doctors use this test to confirm exposure, distinguish acute from prior infection, and support hepatitis B screening and diagnosis.

The Hepatitis B Core IgM Antibody Test is a qualitative test that detects IgM antibodies to the hepatitis B core antigen (anti-HBc IgM) and reports results as Reactive or Non-Reactive. A reactive result indicates a recent or acute hepatitis B infection, while a non-reactive result suggests no active infection. Doctors order this test to confirm acute hepatitis B in patients with symptoms such as jaundice, fatigue, fever, or abdominal pain and to guide treatment and monitoring.

The Hepatitis B Surface Antigen (HBsAg) Test with Reflex to Confirmation screens for hepatitis B surface antigen in blood and, if reactive, automatically performs confirmatory testing. A reactive confirmed result indicates an active hepatitis B infection, while a non-reactive result shows no infection. Doctors use this test to diagnose acute or chronic hepatitis B, investigate abnormal liver tests, and guide treatment, monitoring, and infection control decisions.

The Hepatitis B Test (Hepatitis B Surface Antigen with Reflex to Confirmation) screens for hepatitis B surface antigen (HBsAg) in the blood to identify active infection. If the result is positive, a confirmation test is automatically performed to verify accuracy and support proper diagnosis.

A comprehensive blood test designed to evaluate autoimmune causes of liver inflammation. The Autoimmune Hepatitis Diagnostic Panel measures ANA, mitochondrial antibodies, smooth muscle antibodies, and LKM-1 antibodies to help identify autoimmune hepatitis and related liver disorders. Ideal for investigating unexplained elevated liver enzymes and suspected immune-mediated liver disease.

The General Hepatitis Panel Test screens for multiple hepatitis infections in one order. It includes Hepatitis A Antibody Total, Hepatitis B Surface Antibody Qualitative, Hepatitis B Surface Antigen with Reflex to Confirmation, Hepatitis B Core Antibody Total, and Hepatitis C Antibody with Reflex to RNA PCR. Doctors use this panel to detect past exposure, confirm active or chronic infection, guide treatment, and support liver health monitoring.

The Hepatitis A Antibody Total Test is a qualitative test that detects antibodies to hepatitis A virus (HAV) and reports results as Reactive or Non-Reactive. It does not distinguish between IgM and IgG antibodies. A reactive result may indicate past infection or immunity from vaccination, while a non-reactive result suggests no prior exposure. Doctors use this test to assess immune status, guide vaccination decisions, and evaluate risk of hepatitis A infection.

The Hepatitis A IgM Antibody Test is a qualitative blood test that detects IgM antibodies to the hepatitis A virus (HAV) and reports results as Reactive or Non-Reactive. A reactive result usually indicates a recent or current hepatitis A infection, while a non-reactive result means no active infection. Doctors use this test to confirm acute hepatitis A in patients with symptoms like jaundice, nausea, fatigue, or abdominal pain and to guide timely treatment and prevention.

The Hepatitis B Immunity Panel Test evaluates immune status by measuring Hepatitis B surface antibody levels in the blood. A positive result typically indicates immunity from vaccination or past infection, while a negative result suggests susceptibility. This test is important for verifying protection, monitoring vaccine response, or determining if additional vaccination or further evaluation for Hepatitis B exposure is needed.

The Hepatitis B Surface Antibody Qualitative Test detects anti-HBs antibodies to the hepatitis B surface antigen and reports results as Reactive or Non-Reactive. A reactive result indicates past exposure, either from hepatitis B infection or prior vaccination, while a non-reactive result suggests no detectable exposure. Doctors use this test to confirm hepatitis B exposure history, evaluate vaccine response, and guide further preventive or diagnostic decisions.

The Hepatitis B Surface Antibody Quantitative Test measures the exact level of anti-HBs antibodies in blood to determine past exposure and whether protective immunity has developed from infection or vaccination. A higher antibody level generally indicates adequate immune response, while a low level suggests limited or no protection. Doctors use this test to confirm vaccine effectiveness, assess immune status, and support hepatitis B screening or preventive care.